To summarize the results of the current study, our data suggested that although some metabolic changes do occur to platelet counts and to the interleukin-6 and/or thrombopoietin synthesis in T2DM and in paraneoplastic thrombocytosis-affected CRC patients, no combined effect have been observed. The gene discussed is IL6; the disease is type 2 diabetes mellitus.